US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

PEAR

Pear Therapeutics (PEAR)

Pear Therapeutics Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PEAR

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
02/05/2023	12:37	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:PEAR	Pear Therapeutics Inc
12/04/2023	15:34	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PEAR	Pear Therapeutics Inc
10/04/2023	15:37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PEAR	Pear Therapeutics Inc
07/04/2023	10:30	Business Wire	Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process	NASDAQ:PEAR	Pear Therapeutics Inc
03/04/2023	15:05	GlobeNewswire Inc.	Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer	NASDAQ:PEAR	Pear Therapeutics Inc
31/03/2023	15:04	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PEAR	Pear Therapeutics Inc
17/03/2023	08:15	Business Wire	Pear Therapeutics Announces Process Exploring Strategic Alternatives	NASDAQ:PEAR	Pear Therapeutics Inc
27/02/2023	07:00	Business Wire	Pear Therapeutics to Participate in 43rd Annual Cowen Healthcare Conference	NASDAQ:PEAR	Pear Therapeutics Inc
09/02/2023	15:43	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PEAR	Pear Therapeutics Inc
02/02/2023	07:00	Business Wire	Pear Therapeutics to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	NASDAQ:PEAR	Pear Therapeutics Inc
26/01/2023	07:00	Business Wire	Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders	NASDAQ:PEAR	Pear Therapeutics Inc
24/01/2023	15:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
18/01/2023	07:00	Business Wire	Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List	NASDAQ:PEAR	Pear Therapeutics Inc
17/01/2023	07:00	Business Wire	Pear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series	NASDAQ:PEAR	Pear Therapeutics Inc
12/01/2023	07:00	Business Wire	California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program	NASDAQ:PEAR	Pear Therapeutics Inc
10/01/2023	15:21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:PEAR	Pear Therapeutics Inc
10/01/2023	07:00	Business Wire	Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics	NASDAQ:PEAR	Pear Therapeutics Inc
04/01/2023	15:21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:PEAR	Pear Therapeutics Inc
04/01/2023	07:00	Business Wire	Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States	NASDAQ:PEAR	Pear Therapeutics Inc
04/01/2023	05:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PEAR	Pear Therapeutics Inc
03/01/2023	06:38	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:PEAR	Pear Therapeutics Inc
15/12/2022	07:00	Business Wire	Pear Therapeutics Presents Real-World Clinical Data Assessing Engagement and Abstinence in Patients with Alcohol Use Disorders Using reSET® at AAAP	NASDAQ:PEAR	Pear Therapeutics Inc
21/11/2022	07:00	Business Wire	Pear Therapeutics to Participate in Evercore ISI 5th Annual HealthCONx Conference	NASDAQ:PEAR	Pear Therapeutics Inc
14/11/2022	18:45	TipRanks	Pear Therapeutics (PEAR) Receives a Buy from BTIG	NASDAQ:PEAR	Pear Therapeutics Inc
14/11/2022	16:53	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PEAR	Pear Therapeutics Inc
14/11/2022	15:02	Business Wire	Pear Therapeutics Reports Third Quarter 2022 Results	NASDAQ:PEAR	Pear Therapeutics Inc
10/11/2022	07:00	Business Wire	Pear Therapeutics to Participate in the BTIG Digital Health Forum	NASDAQ:PEAR	Pear Therapeutics Inc
07/11/2022	07:00	Business Wire	Pear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® at ISPOR Europe	NASDAQ:PEAR	Pear Therapeutics Inc
03/11/2022	07:00	Business Wire	State of Wisconsin to Provide Access to Prescription Digital Therapeutics to Help Local Communities Fight Against Addiction Crisis	NASDAQ:PEAR	Pear Therapeutics Inc
01/11/2022	15:02	Business Wire	Pear Therapeutics to Participate in the Credit Suisse 31st Annual Healthcare Conference	NASDAQ:PEAR	Pear Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:PEAR

1 2 3 4 Próxima >

Energy Select Sector SPDR

Euro vs US Dollar

Deutsche Telekom (QX)

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones